As of December 2024, the company held about $1.2 billion of cash and ... Since purchasing Solexa with its Genome Reader instrument in 2007, Illumina’s continued innovation significantly reduced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback